Report Detail

Request for Sample of this report

Other Global LFA-based Cardiac Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4667611
    • |
  • 22 January, 2026
    • |
  • Global
    • |
  • 105 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global LFA-based Cardiac market size was valued at US$ 4608 million in 2025 and is forecast to a readjusted size of US$ 6662 million by 2032 with a CAGR of 5.5% during review period.
Lateral flow cardiac markers are a rapid detection tool based on lateral flow immunochromatography technology, which is used to qualitatively or quantitatively detect specific cardiac biomarkers in the blood (such as troponin I/T, myoglobin, BNP, etc.). The principle is to form a visual detection line on the test strip through antigen-antibody reaction, so as to quickly judge abnormal cardiac function or myocardial damage. This technology has the advantages of convenience, rapidity (results in 15-30 minutes), low cost, and no need for complex equipment. It is widely used in emergency, primary care, home self-testing and other scenarios.
Market drivers:
Disease demand growth:
Cardiovascular disease is the world's leading cause of death, with a large and growing patient base. China has more than 330 million cardiovascular disease patients, and there is an urgent need for early screening and immediate diagnosis.
Acute myocardial infarction, heart failure and other acute diseases require rapid testing (such as the demand for troponin immediate testing in chest pain centers), and lateral flow technology can shorten the diagnosis time and improve prognosis.
Policy promotion:
Tiered diagnosis and treatment: Policies guide the sinking of high-quality medical resources, and primary medical institutions (such as community hospitals and township health centers) need to be equipped with POCT (point-of-care testing) equipment. Lateral flow cardiac markers are the first choice because of their simple operation and low cost.
Medical insurance coverage: Some cardiac marker tests are included in medical insurance, reducing the burden on patients and improving the accessibility of testing.
Technology iteration:
Sensitivity improvement: The application of nanomaterials (such as gold nanoparticles) improves detection sensitivity and can detect low-concentration markers (such as high-sensitivity troponin).
Multi-indicator joint detection: The same test strip realizes the joint detection of multiple markers (such as troponin + BNP + D-dimer), improving diagnostic efficiency.
Intelligence: Combined with mobile phone APP or portable reader, the results can be automatically transmitted and interpreted to reduce human errors.
Application scenario expansion:
Pre-hospital emergency: rapid screening at ambulance and emergency scene, auxiliary decision-making (such as whether to transfer directly to the catheterization room).
Home monitoring: patients with chronic heart failure can self-test BNP at home and adjust drug dosage in time.
Physical examination screening: early cardiac function assessment for high-risk groups (such as patients with hypertension and diabetes).
Market trend:
Domestic substitution: domestic companies (such as Wondfo Biotech and Mindray Biotech) have made technological breakthroughs, breaking the import monopoly and reducing costs.
Standardized development: industry standards are gradually improved, promoting the transformation of product homogeneity to differentiated competition (such as specific marker detection and personalized services).
The lateral flow cardiac marker market is driven by disease demand, policy promotion, and technological upgrading. In the future, it will continue to develop in the direction of rapidity, multi-indicators, and intelligence, and become an important tool for the diagnosis and treatment of cardiovascular diseases.
This report is a detailed and comprehensive analysis for global LFA-based Cardiac market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global LFA-based Cardiac market size and forecasts, in consumption value ($ Million), 2021-2032
Global LFA-based Cardiac market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global LFA-based Cardiac market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global LFA-based Cardiac market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for LFA-based Cardiac
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global LFA-based Cardiac market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, Siemens, Danaher, Bio-Rad Laboratories, BioMérieux, Thermo Fisher, Ortho Clinical Diagnostics, LSI Medience Corporation, Randox laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
LFA-based Cardiac market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Troponin I
Troponin T
CK-MB
Myoglobin
Others
Market segment by Application
Laboratory Testing
Point-of-care Testing
Market segment by players, this report covers
Roche
Abbott
Siemens
Danaher
Bio-Rad Laboratories
BioMérieux
Thermo Fisher
Ortho Clinical Diagnostics
LSI Medience Corporation
Randox laboratories
Wondfo Biotech
EasyDiagnosis Biomedicine
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe LFA-based Cardiac product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of LFA-based Cardiac, with revenue, gross margin, and global market share of LFA-based Cardiac from 2021 to 2026.
Chapter 3, the LFA-based Cardiac competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and LFA-based Cardiac market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of LFA-based Cardiac.
Chapter 13, to describe LFA-based Cardiac research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of LFA-based Cardiac by Type
    • 1.3.1 Overview: Global LFA-based Cardiac Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global LFA-based Cardiac Consumption Value Market Share by Type in 2025
    • 1.3.3 Troponin I
    • 1.3.4 Troponin T
    • 1.3.5 CK-MB
    • 1.3.6 Myoglobin
    • 1.3.7 Others
  • 1.4 Global LFA-based Cardiac Market by Application
    • 1.4.1 Overview: Global LFA-based Cardiac Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Laboratory Testing
    • 1.4.3 Point-of-care Testing
  • 1.5 Global LFA-based Cardiac Market Size & Forecast
  • 1.6 Global LFA-based Cardiac Market Size and Forecast by Region
    • 1.6.1 Global LFA-based Cardiac Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global LFA-based Cardiac Market Size by Region, (2021-2032)
    • 1.6.3 North America LFA-based Cardiac Market Size and Prospect (2021-2032)
    • 1.6.4 Europe LFA-based Cardiac Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific LFA-based Cardiac Market Size and Prospect (2021-2032)
    • 1.6.6 South America LFA-based Cardiac Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa LFA-based Cardiac Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche LFA-based Cardiac Product and Solutions
    • 2.1.4 Roche LFA-based Cardiac Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Abbott
    • 2.2.1 Abbott Details
    • 2.2.2 Abbott Major Business
    • 2.2.3 Abbott LFA-based Cardiac Product and Solutions
    • 2.2.4 Abbott LFA-based Cardiac Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Abbott Recent Developments and Future Plans
  • 2.3 Siemens
    • 2.3.1 Siemens Details
    • 2.3.2 Siemens Major Business
    • 2.3.3 Siemens LFA-based Cardiac Product and Solutions
    • 2.3.4 Siemens LFA-based Cardiac Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Siemens Recent Developments and Future Plans
  • 2.4 Danaher
    • 2.4.1 Danaher Details
    • 2.4.2 Danaher Major Business
    • 2.4.3 Danaher LFA-based Cardiac Product and Solutions
    • 2.4.4 Danaher LFA-based Cardiac Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Danaher Recent Developments and Future Plans
  • 2.5 Bio-Rad Laboratories
    • 2.5.1 Bio-Rad Laboratories Details
    • 2.5.2 Bio-Rad Laboratories Major Business
    • 2.5.3 Bio-Rad Laboratories LFA-based Cardiac Product and Solutions
    • 2.5.4 Bio-Rad Laboratories LFA-based Cardiac Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Bio-Rad Laboratories Recent Developments and Future Plans
  • 2.6 BioMérieux
    • 2.6.1 BioMérieux Details
    • 2.6.2 BioMérieux Major Business
    • 2.6.3 BioMérieux LFA-based Cardiac Product and Solutions
    • 2.6.4 BioMérieux LFA-based Cardiac Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 BioMérieux Recent Developments and Future Plans
  • 2.7 Thermo Fisher
    • 2.7.1 Thermo Fisher Details
    • 2.7.2 Thermo Fisher Major Business
    • 2.7.3 Thermo Fisher LFA-based Cardiac Product and Solutions
    • 2.7.4 Thermo Fisher LFA-based Cardiac Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Thermo Fisher Recent Developments and Future Plans
  • 2.8 Ortho Clinical Diagnostics
    • 2.8.1 Ortho Clinical Diagnostics Details
    • 2.8.2 Ortho Clinical Diagnostics Major Business
    • 2.8.3 Ortho Clinical Diagnostics LFA-based Cardiac Product and Solutions
    • 2.8.4 Ortho Clinical Diagnostics LFA-based Cardiac Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Ortho Clinical Diagnostics Recent Developments and Future Plans
  • 2.9 LSI Medience Corporation
    • 2.9.1 LSI Medience Corporation Details
    • 2.9.2 LSI Medience Corporation Major Business
    • 2.9.3 LSI Medience Corporation LFA-based Cardiac Product and Solutions
    • 2.9.4 LSI Medience Corporation LFA-based Cardiac Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 LSI Medience Corporation Recent Developments and Future Plans
  • 2.10 Randox laboratories
    • 2.10.1 Randox laboratories Details
    • 2.10.2 Randox laboratories Major Business
    • 2.10.3 Randox laboratories LFA-based Cardiac Product and Solutions
    • 2.10.4 Randox laboratories LFA-based Cardiac Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Randox laboratories Recent Developments and Future Plans
  • 2.11 Wondfo Biotech
    • 2.11.1 Wondfo Biotech Details
    • 2.11.2 Wondfo Biotech Major Business
    • 2.11.3 Wondfo Biotech LFA-based Cardiac Product and Solutions
    • 2.11.4 Wondfo Biotech LFA-based Cardiac Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Wondfo Biotech Recent Developments and Future Plans
  • 2.12 EasyDiagnosis Biomedicine
    • 2.12.1 EasyDiagnosis Biomedicine Details
    • 2.12.2 EasyDiagnosis Biomedicine Major Business
    • 2.12.3 EasyDiagnosis Biomedicine LFA-based Cardiac Product and Solutions
    • 2.12.4 EasyDiagnosis Biomedicine LFA-based Cardiac Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 EasyDiagnosis Biomedicine Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global LFA-based Cardiac Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of LFA-based Cardiac by Company Revenue
    • 3.2.2 Top 3 LFA-based Cardiac Players Market Share in 2025
    • 3.2.3 Top 6 LFA-based Cardiac Players Market Share in 2025
  • 3.3 LFA-based Cardiac Market: Overall Company Footprint Analysis
    • 3.3.1 LFA-based Cardiac Market: Region Footprint
    • 3.3.2 LFA-based Cardiac Market: Company Product Type Footprint
    • 3.3.3 LFA-based Cardiac Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global LFA-based Cardiac Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global LFA-based Cardiac Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global LFA-based Cardiac Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global LFA-based Cardiac Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America LFA-based Cardiac Consumption Value by Type (2021-2032)
  • 6.2 North America LFA-based Cardiac Market Size by Application (2021-2032)
  • 6.3 North America LFA-based Cardiac Market Size by Country
    • 6.3.1 North America LFA-based Cardiac Consumption Value by Country (2021-2032)
    • 6.3.2 United States LFA-based Cardiac Market Size and Forecast (2021-2032)
    • 6.3.3 Canada LFA-based Cardiac Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico LFA-based Cardiac Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe LFA-based Cardiac Consumption Value by Type (2021-2032)
  • 7.2 Europe LFA-based Cardiac Consumption Value by Application (2021-2032)
  • 7.3 Europe LFA-based Cardiac Market Size by Country
    • 7.3.1 Europe LFA-based Cardiac Consumption Value by Country (2021-2032)
    • 7.3.2 Germany LFA-based Cardiac Market Size and Forecast (2021-2032)
    • 7.3.3 France LFA-based Cardiac Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom LFA-based Cardiac Market Size and Forecast (2021-2032)
    • 7.3.5 Russia LFA-based Cardiac Market Size and Forecast (2021-2032)
    • 7.3.6 Italy LFA-based Cardiac Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific LFA-based Cardiac Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific LFA-based Cardiac Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific LFA-based Cardiac Market Size by Region
    • 8.3.1 Asia-Pacific LFA-based Cardiac Consumption Value by Region (2021-2032)
    • 8.3.2 China LFA-based Cardiac Market Size and Forecast (2021-2032)
    • 8.3.3 Japan LFA-based Cardiac Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea LFA-based Cardiac Market Size and Forecast (2021-2032)
    • 8.3.5 India LFA-based Cardiac Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia LFA-based Cardiac Market Size and Forecast (2021-2032)
    • 8.3.7 Australia LFA-based Cardiac Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America LFA-based Cardiac Consumption Value by Type (2021-2032)
  • 9.2 South America LFA-based Cardiac Consumption Value by Application (2021-2032)
  • 9.3 South America LFA-based Cardiac Market Size by Country
    • 9.3.1 South America LFA-based Cardiac Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil LFA-based Cardiac Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina LFA-based Cardiac Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa LFA-based Cardiac Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa LFA-based Cardiac Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa LFA-based Cardiac Market Size by Country
    • 10.3.1 Middle East & Africa LFA-based Cardiac Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey LFA-based Cardiac Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia LFA-based Cardiac Market Size and Forecast (2021-2032)
    • 10.3.4 UAE LFA-based Cardiac Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 LFA-based Cardiac Market Drivers
  • 11.2 LFA-based Cardiac Market Restraints
  • 11.3 LFA-based Cardiac Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 LFA-based Cardiac Industry Chain
  • 12.2 LFA-based Cardiac Upstream Analysis
  • 12.3 LFA-based Cardiac Midstream Analysis
  • 12.4 LFA-based Cardiac Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on LFA-based Cardiac. Industry analysis & Market Report on LFA-based Cardiac is a syndicated market report, published as Global LFA-based Cardiac Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of LFA-based Cardiac market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo